These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Gene therapy for head and neck cancer. Frank DK Surg Oncol Clin N Am; 2002 Jul; 11(3):589-606, vi-vii. PubMed ID: 12492081 [TBL] [Abstract][Full Text] [Related]
4. Advances in the techniques and methodologies of cancer gene therapy. Sun W; Shi Q; Zhang H; Yang K; Ke Y; Wang Y; Qiao L Discov Med; 2019 Jan; 27(146):45-55. PubMed ID: 30721651 [TBL] [Abstract][Full Text] [Related]
5. Prostate cancer gene therapy. Ferrer FA; Rodriguez R Hematol Oncol Clin North Am; 2001 Jun; 15(3):497-508. PubMed ID: 11525293 [TBL] [Abstract][Full Text] [Related]
6. Gene therapy in prostate cancer: past, present and future. Shirakawa T; Fujisawa M; Gotoh A Front Biosci; 2008 Jan; 13():2115-9. PubMed ID: 17981696 [TBL] [Abstract][Full Text] [Related]
7. Biological principles and clinical development of prostate cancer gene therapy. Sanda MG Semin Urol Oncol; 1997 Feb; 15(1):43-55. PubMed ID: 9050139 [TBL] [Abstract][Full Text] [Related]
8. Prospects for gene therapy in human prostate cancer. Ficazzola MA; Taneja SS Mol Med Today; 1998 Nov; 4(11):494-504. PubMed ID: 9857369 [TBL] [Abstract][Full Text] [Related]
9. [Is gene therapy of advanced prostatic carcinoma on the verge of clinical application?]. Gschwend JE; Hautmann RE Urologe A; 1998 Mar; 37(2):172-4. PubMed ID: 9563131 [TBL] [Abstract][Full Text] [Related]
10. Clinical trials for cancer gene therapy. Cusack JC Surg Oncol Clin N Am; 2002 Jul; 11(3):717-825. PubMed ID: 12487064 [No Abstract] [Full Text] [Related]
11. Cotargeting tumor and tumor endothelium effectively inhibits the growth of human prostate cancer in adenovirus-mediated antiangiogenesis and oncolysis combination therapy. Jin F; Xie Z; Kuo CJ; Chung LW; Hsieh CL Cancer Gene Ther; 2005 Mar; 12(3):257-67. PubMed ID: 15565180 [TBL] [Abstract][Full Text] [Related]
12. Current challenges of gene therapy for prostate cancer. Harrison GS; Glode LM Oncology (Williston Park); 1997 Jun; 11(6):845-50, 856; discussion 856-8, 861. PubMed ID: 9189941 [TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for prostate cancer - recent progress in clinical trials. Kipp RT; McNeel DG Clin Adv Hematol Oncol; 2007 Jun; 5(6):465-74, 477-9. PubMed ID: 17679921 [TBL] [Abstract][Full Text] [Related]
14. Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase gene. Shalev M; Miles BJ; Thompson TC; Ayala G; Butler EB; Aguilar-Cordova E; Kadmon D World J Urol; 2000 Apr; 18(2):125-9. PubMed ID: 10854147 [TBL] [Abstract][Full Text] [Related]
15. The prospect of gene therapy for prostate cancer: update on theory and status. Koeneman KS; Hsieh JT Curr Opin Urol; 2001 Sep; 11(5):489-94. PubMed ID: 11493770 [TBL] [Abstract][Full Text] [Related]
16. In situ gene therapy for prostate cancer. Satoh T; Irie A; Egawa S; Baba S Curr Gene Ther; 2005 Feb; 5(1):111-9. PubMed ID: 15638715 [TBL] [Abstract][Full Text] [Related]
17. Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy. Hwang C; Sanda MG Curr Opin Mol Ther; 1999 Aug; 1(4):471-9. PubMed ID: 11713762 [TBL] [Abstract][Full Text] [Related]
18. Viral-mediated gene transfer for cancer treatment. Wilson DR Curr Pharm Biotechnol; 2002 Jun; 3(2):151-64. PubMed ID: 12022258 [TBL] [Abstract][Full Text] [Related]
19. Novel therapies for the treatment of prostate cancer: current clinical trials and development strategies. Morris MJ; Scher HI Surg Oncol; 2002 Jun; 11(1-2):13-23. PubMed ID: 12031864 [TBL] [Abstract][Full Text] [Related]
20. Chemotherapy and immunotherapy combination in advanced prostate cancer. Slovin S Clin Adv Hematol Oncol; 2012 Feb; 10(2):90-100. PubMed ID: 22402350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]